Diabetes Ther (2021) 12:80111
10.1038/nrendo.2017.173 11
The SURMOUNT-1 trial evaluating tirzepatide showed more pronounced effects, with participants losing 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) of body weight at 72 weeks
You are the best! I could not have asked for better care
A quick self-check for mole shifts Look for these signs and act fast if you see them: One spot that looks different from the rest A border that looks jagged instead of smooth Two or more colors in the same spot A spot that grows fast A spot that itches, bleeds, or crusts If any of these show up, book a dermatology visit
Although the two companies have adopted different strategiesLilly rapidly expanding capacity while Novo further integrating its manufacturing networkthey are both pursuing the same objective: securing long-term supply in a market where manufacturing has become a decisive competitive advantage